@article{11beca583af84d538d000377c6d498a2,
title = "Added value of drug-laboratory test interaction alerts in test result authorisation",
keywords = "Clinical Decision Support System (CDSS), Diagnostic error, Drug-laboratory test interaction (DLTI), Laboratory test, Patient safety, NLA",
author = "\{van Balveren\}, \{Jasmijn A.\} and \{Verboeket-van de Venne\}, \{Wilhelmine P.H.G.\} and Doggen, \{Carine J.M.\} and Lale Erdem-Eraslan and \{de Graaf\}, \{Albert J.\} and Krabbe, \{Johannes G.\} and Musson, \{Ruben E.A.\} and Oosterhuis, \{Wytze P.\} and \{De Rijke\}, \{Yolanda B.\} and \{van der Sijs\}, Heleen and Tintu, \{Andrei N.\} and Verheul, \{Rolf J.\} and Hoedemakers, \{Rein M.J.\} and Ron Kusters",
note = "Funding Information: Research funding: This study received funding from Stichting Kwaliteitsgelden Medisch Specialisten (SKMS), grant number 42678870. ",
year = "2022",
month = apr,
day = "26",
doi = "10.1515/cclm-2022-0077",
language = "English",
volume = "60",
pages = "E108--E111",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH",
number = "5",
}